This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Corporation Du Centre De Recherche Du Centre, Hospitalier Du L′universite De Montreal, Kiacta Sarl. Active years: 2004-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 2 Years Active: 2004-2013
Title: Pavel Hamet: Innovator in Renal Disorders and Apoptosis Research
Introduction
Pavel Hamet is a distinguished inventor based in Ville Mont-Royal, Canada. He has made significant contributions to the field of medical research, particularly in the treatment of renal disorders and apoptosis-related pathologies. With a total of 2 patents, his work has the potential to impact the lives of many patients suffering from chronic kidney diseases and related complications.
Latest Patents
Hamet's latest patents focus on innovative methods and compositions for preventing and treating renal disorders, including diabetic nephropathy. One of his notable inventions involves the administration of 1,3-propanedisulfonic acid or its pharmaceutically acceptable salts to treat chronic kidney diseases. This invention aims to reduce harmful serum lipid levels, particularly cholesterol and triglycerides, in diabetic patients. Another significant patent explores the use of ouabain and ouabain-like molecules in apoptosis-related pathologies. His research demonstrates that the inhibition of the Na/K pump in vascular smooth muscle cells can protect against apoptosis, highlighting the importance of maintaining a low intracellular Na/K ratio for cell survival.
Career Highlights
Throughout his career, Pavel Hamet has worked with various esteemed organizations, including the Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Kiacta Sarl. His research has garnered attention for its innovative approaches to complex medical issues, particularly in the realm of renal health.
Collaborations
Hamet has collaborated with notable colleagues such as Sergei N Orlov and Johanne Tremblay. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Pavel Hamet's contributions to the field of medical research, particularly in renal disorders and apoptosis, showcase his innovative spirit and dedication to improving patient outcomes. His patents reflect a commitment to advancing medical science and addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile